The global ambulatory surgical equipment market is valued at USD 7.39 billion in 2026 and is expected to reach USD 14.58 billion by 2035, growing at a 7.85% CAGR. North America dominates with 34% market share, while Asia Pacific is the fastest-growing region. Endoscopy and laparoscopy systems lead by product type at 18% share, with compact intraoperative imaging expected to grow fastest. Independent ambulatory surgical centers account for 42% of the market.

Stryker announced it will release its first quarter fiscal year 2026 financial results on April 30, 2026, with a press release at 4:05 p.m. ET followed by a webcast at 4:30 p.m. ET to discuss the results for the quarter ended March 31, 2026.

Boston Scientific shares fell 9.02% on March 30, 2026, after the company announced results from its CHAMPION-AF clinical trial for the Watchman FLX heart implant. While the trial met all safety and efficacy endpoints, analysts considered the results underwhelming and expressed concerns that growth may not accelerate as expected. Despite the decline, analysts maintained outperform ratings, noting the stock is reasonably valued at 18x forward earnings.

Stryker announced its 2026 Annual Meeting of Shareholders scheduled for May 6, 2026, to be held virtually. The company also declared a quarterly dividend of $0.88 per share payable on April 30, 2026. Stryker is a global leader in medical technologies serving over 150 million patients annually across MedSurg, Neurotechnology, and Orthopaedics segments.

The global orthobiologics market is projected to grow from USD 6.68 billion in 2025 to USD 9.52 billion by 2031, with a CAGR of 6.17%. Growth is driven by rising osteoarthritis cases, sports-related injuries, and advancements in regenerative therapies including stem cell therapy and platelet-rich plasma treatments. North America leads the market while Asia-Pacific is the fastest-growing region.

Stryker Corporation experienced a widespread cyber disruption affecting its global technology systems after midnight on March 11, 2026. Employees discovered their Windows devices were wiped, and login pages displayed the logo of Handala, an Iran-linked pro-Palestinian hacking group. The company instructed staff to disconnect from corporate networks and avoid powering on company devices. Stryker shares fell 3.82% to $344.96 as the company works with Microsoft to investigate the incident.

The global medical device cleaning market is projected to grow from USD 2.08 billion in 2024 to USD 3.74 billion by 2032, driven by escalating infection prevention requirements, expanding reusable device utilization, and technological advancements in automated reprocessing systems. However, high capital costs, complex regulatory obligations, and workforce training variability pose challenges to uniform adoption across regions.

The global rigid endoscopes market is projected to grow from USD 7.36 billion in 2025 to USD 11.52 billion by 2033, at a CAGR of 5.84%. Growth is driven by technological advancements in HD and 4K imaging, increasing adoption of minimally invasive procedures across multiple surgical specialties, and the rapid expansion of ambulatory surgery centers. North America leads with 41% market share, while Asia-Pacific is expected to register the highest growth rate at 8.00%.

The global fibrin sealant market is projected to grow from USD 1.60 billion in 2025 to USD 3.57 billion by 2035 at a CAGR of 8.37%, driven by increasing surgical volumes, minimally invasive procedures, and expanding applications in trauma and wound care. However, high costs and insurance coverage limitations remain barriers to adoption in emerging markets.

The global uterine fibroid market is projected to grow from USD 5.26 billion in 2025 to USD 9.43 billion by 2033 at a CAGR of 7.63%. Growth is driven by rising prevalence of fibroids (affecting 70-80% of women by age 50), technological advances in minimally invasive procedures with 60% adoption increase, and expanded healthcare infrastructure in emerging markets. Minimally invasive procedures and MRI-guided focused ultrasound are expected to see the fastest growth rates.

The global clinical communication and collaboration market is projected to grow from US$ 2,942.90 million in 2024 to US$ 9,430.65 million by 2033, driven by telemedicine expansion, cloud-based solutions, and wearable medical devices. Hospitals dominate as primary users, while North America leads with over 40% global adoption. Cloud-based solutions captured over 55% of the software deployment market share in 2024.

The global orthopedic implants market is projected to grow from USD 23.50 billion in 2025 to USD 33.20 billion by 2033, expanding at a CAGR of 4.43%. Growth is driven by rising musculoskeletal disorders, aging populations, technological advancements in biomaterials and minimally invasive procedures, and digital orthopedic solutions. However, high implant costs, strict regulatory requirements, and pricing pressures from healthcare providers remain key challenges.